Federal Register / Vol. 73, No. 21 / Thursday, January 31, 2008 / Notices 5839 

public will be requested to provide 

relevant information or other 

documentation on nominees that the 

SAB Staff Office should consider in 

evaluating candidates. 

For the EPA SAB Staff Office, a 

balanced subcommittee or review panel 

includes candidates who possess the 

necessary domains of knowledge, the 

relevant scientific perspectives (which, 

among other factors, can be influenced 

by work history and affiliation), and the 

collective breadth of experience to 

adequately address the charge. In 

establishing the final SAB PM Research 

Centers Program Review Panel, the SAB 

Staff Office will consider public 

comments on the ‘‘Short List’’ of 

candidates, information provided by the 

candidates themselves, and background 

information independently gathered by 

the SAB Staff Office. Specific criteria to 

be used for Panel membership include: 

(a) Scientific and/or technical expertise, 

knowledge, and experience (primary 

factors); (b) availability and willingness 

to serve; (c) absence of financial 

conflicts of interest; (d) absence of an 

appearance of a lack of impartiality; and 

(e) skills working in committees, 

subcommittees and advisory panels; 

and, for the Panel as a whole, (f) 

diversity of, and balance among, 

scientific expertise, viewpoints, etc. 

The SAB Staff Office’s evaluation of 

an absence of financial conflicts of 

interest will include a review of the 

‘‘Confidential Financial Disclosure 

Form for Special Government 

Employees Serving on Federal Advisory 

Committees at the U.S. Environmental 

Protection Agency’’ (EPA Form 3110–

48). This confidential form allows 

Government officials to determine 

whether there is a statutory conflict 

between that person’s public 

responsibilities (which includes 

membership on an EPA Federal 

advisory committee) and private 

interests and activities, or the 

appearance of a lack of impartiality, as 

defined by Federal regulation. The form 

may be viewed and downloaded from 

the following SAB Web site: http:// 

yosemite.epa.gov/sab/sabproduct.nsf/ 

Web/Ethics?OpenDocument. 

The approved policy under which the 

EPA SAB Office selects subcommittees 

and review panels is described in the 

following document: Overview of the 

Panel Formation Process at the 

Environmental Protection Agency 

Science Advisory Board (EPA–SAB–EC–

02–010, September 2002), which is 

posted on the SAB Web site: http:// 

yosemite.epa.gov/sab/sabproduct.nsf/

WebSABSO/ 

OverviewPanelForm?OpenDocument. 

Dated: January 25, 2008. 

Anthony Maciorowski, 

Deputy Director, EPA Science Advisory Board 

Staff Office. 

[FR Doc. E8–1774 Filed 1–30–08; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPP–2008–0002; FRL–8349–3] 

System Research and Application 

Corporation; Transfer of Data 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: This notice announces that 

pesticide related information submitted 

to EPA’s Office of Pesticide Programs 

(OPP) pursuant to the Federal 

Insecticide, Fungicide, and Rodenticide 

Act (FIFRA) and the Federal Food, Drug, 

and Cosmetic Act (FFDCA), including 

information that may have been claimed 

as Confidential Business Information 

(CBI) by the submitter, will be tranferred 

to the System Research and Application 

Corporation, in accordance with 40 CFR 

2.309(c) and 2.308(h)(2). The System 

Research and Application Corporation, 

will perform work for OPP under an 

Interagency Agreement (IAG). Access to 

this information will enable System 

Research and Application Corporation, 

to fulfill the obligations of the IAG. 

DATES: The System Research and 

Application Corporation, will be given 

access to this information on or before 

February 11, 2008. 

FOR FURTHER INFORMATION CONTACT: 

Felicia Croom, Information Technology 

and Resources Management Division 

(7502P), Office of Pesticide Programs, 

Environmental Protection Agency, 1200 

Pennsylvania Ave., NW., Washington, 

DC 20460–0001; telephone number: 

(703) 305–0786; e-mail address: 

croom.felicia@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this Action Apply to Me? 

This action applies to the public in 

general. As such, the Agency has not 

attempted to describe all the specific 

entities that may be affected by this 

action. If you have any questions 

regarding the applicability of this action 

to a particular entity, consult the person 

listed under FOR FURTHER INFORMATION

CONTACT. 

B. How Can I Get Copies of this 

Document and Other Related 

Information? 

1. Docket. EPA has established a 

docket for this action under docket 

identification (ID) number EPA–HQ–

OPP–2008–0002. Publicly available 

docket materials are available either in 

the electronic docket at http:// 

www.regulations.gov, or, if only 

available in hard copy, at the Office of 

Pesticide Programs (OPP) Regulatory 

Public Docket in Rm. S–4400, One 

Potomac Yard (South Bldg.), 2777 S. 

Crystal Dr., Arlington, VA. The hours of 

operation of this Docket Facility are 

from 8:30 a.m. to 4 p.m., Monday 

through Friday, excluding legal 

holidays. The Docket Facility telephone 

number is (703) 305–5805. 

2. Electronic access. You may access 

this Federal Register document 

electronically through the EPA Internet 

under the ‘‘Federal Register’’ listings at 

http://www.epa.gov/fedrgstr. 

II. Contractor Requirements 

Under IAG No. EP-W-050-24, which 

supports the OPP’s regulatory efforts, 

the System Research and Application 

Corporation, will perform configuration 

management and monitor tasks for the 

Office of Information Technology 

Resources Management Division. 

The OPP has determined that the IAG 

described involves work that is being 

conducted in connection with FIFRA, in 

that pesticide chemicals will be the 

subject of certain evaluations to be made 

under this IAG. These evaluations may 

be used in subsequent regulatory 

decisions under FIFRA. 

Some of this information may be 

entitled to confidential treatment. The 

information has been submitted to EPA 

under sections 3, 4, 6, and 7 of FIFRA 

and under sections 408 and 409 of 

FFDCA. 

In accordance with the requirements 

of 40 CFR 2.309(c), 2.307(h), and 

2.308(h)(2), this IAG with the System 

Research and Application Corporation, 

prohibits use of the information for any 

purpose not specified in the IAG; 

prohibits disclosure of the information 

to a third party without prior written 

approval from the Agency; and requires 

that each official and employee of the 

subcontractor sign an agreement to 

protect the information from 

unauthorized release and to handle it in 

accordance with the FIFRA Information 

Security Manual. In addition, the 

System Research and Application 

Corporation, are required to submit for 

EPA approval a security plan under 

which any CBI will be secured and 

protected against unauthorized release 


rwilkins on PROD1PC63 with NOTICES
5840 Federal Register / Vol. 73, No. 21 / Thursday, January 31, 2008 / Notices 

or compromise. No information will be 

provided to the System Research and 

Application Corporation, until the 

requirements in this document have 

been fully satisfied. Records of 

information provided under this IAG 

will be maintained by EPA Project 

Officers for this contract. All 

information supplied to the System 

Research and Application Corporation, 

by EPA for use in connection with this 

IAG will be returned to EPA when the 

System Research and Application 

Corporation, have completed their work. 

List of Subjects 

Environmental protection, Business 

and industry, Government contracts, 

Government property, Security 

measures. 

Dated: January 23, 2008. 

Oscar Morales, 

Acting Director, Office of Pesticide Programs. 

[FR Doc. E8–1796 Filed 1–30–08; 8:45 am] 

BILLING CODE 6560–50–S 

EQUAL EMPLOYMENT OPPORTUNITY 

COMMISSION 

Sunshine Act Meeting 

AGENCY HOLDING THE MEETING: Equal 

Employment Opportunity Commission. 

DATE AND TIME: Thursday, February 7, 

2008, 2 p.m. Eastern Time. 

PLACE: Clarence M. Mitchell, Jr. 

Conference Room on the Ninth Floor of 

the EEOC Office Building, 1801 ‘‘L’’

Street, NW., Washington, DC 20507. 

STATUS: The meeting will be open to the 

public. 

MATTERS TO BE CONSIDERED: 

Open Session: 

1. Announcement of Notation Votes, 

and 

2. Obligation of Funds for a 

Temporary Interactive Voice Response/ 

Automatic Call Distribution (IVR/ACD) 

Non-competitive Hosting Contract and a 

Competitive Contract for Technology 

Support of Customer Response 

Function. 

Note: In accordance with the Sunshine Act, 

the meeting will be open to public 

observation of the Commission’s 

deliberations and voting. (In addition to 

publishing notices on EEOC Commission 

meetings in the Federal Register the 

Commission also provides a recorded 

announcement a full week in advance on 

future Commission sessions.) 

Please telephone (202) 663–7100 

(voice) and (202) 663–4074 (TTY) at any 

time for information on these meetings. 

The EEOC provides sign language 

interpretation at Commission meetings 

for the hearing impaired. Requests for 

other reasonable accommodations may 

be made by using the voice and TTY 

numbers listed above. Contact Person 

For More Information: Stephen 

Llewellyn, Executive Officer on (202) 

663–4070. 

Dated: January 29, 2008. 

Stephen Llewellyn, 

Executive Officer, Executive Secretariat. 

[FR Doc. 08–454 Filed 1–29–08; 11:41 am] 

BILLING CODE 6570–01–M 

OFFICE OF SCIENCE AND 

TECHNOLOGY POLICY 

Notice of Decision Under Section 

127(f) of the Public Health Security and 

Bioterrorism Preparedness and 

Response Act of 2002 

AGENCY: Office of Science and 

Technology Policy, Executive Office of 

the President. 

ACTION: Notice of Decision to Waive 

Requirements of Sections 127(a) and (d) 

of the Public Health Security and 

Bioterrorism Preparedness and 

Response Act of 2002. Notice of 

Availability of Associated OSTP 

Director’s Decision Memorandum and 

Interagency Technical Evaluation 

Report. 

SUMMARY: Notice is hereby given of the 

determination, under Section 127(f) of 

the Public Health Security and 

Bioterrorism Preparedness and 

Response Act of 2002 (the Act), to waive 

the requirements of Section 127(a) and 

(d) of the Act. Notice is also given that 

the Associated Decision Memorandum 

and an interagency technical analysis 

report are available on the Office of 

Science and Technology Policy (OSTP) 

Web site at http://www.ostp.gov/KI. 

Section 127(a) of the Act directed the 

President to establish a Potassium 

Iodide (KI) distribution program, under 

which State and local governments 

could receive KI tablets for distribution 

to the population in the 20 mile radius 

surrounding nuclear power plants 

(NPPs). The Nuclear Regulatory 

Commission (NRC) already has such a 

program for the 10 mile emergency 

planning zones surrounding NPPs, so 

Section 127(a) effectively extended that 

program to the 10–20 mile range. 

Through Section 127(f), Congress 

authorized the President to waive this 

distribution requirement if there exists 

‘‘an alternative and more effective 

prophylaxis or preventive measures for 

adverse thyroid conditions that may 

result from the release of radionuclides 

from nuclear power plants.’’

On July 3, 2007, the President 

delegated the Section 127(f) waiver 

authority to the Director of the Office of 

Science and Technology Policy. 

On July 30, 2007, to help inform his 

decision, the OSTP Director requested 

the Federal Radiological Policy 

Coordinating Committee (FRPCC) to 

provide a technical evaluation of the 

issues surrounding Section 127. The 

FRPCC is an interagency organization, 

with membership from 17 Federal 

agencies, established to coordinate 

Federal responsibilities for assisting 

State and local governments in 

emergency planning and preparedness 

for peacetime nuclear emergencies. The 

FRPCC transmitted its final technical 

evaluation paper to the OSTP Director 

on October 23, 2007. 

On January 22, 2008, the OSTP 

Director executed his final decision 

pursuant to the Section 127(f) 

delegation. The complete Decision 

Memorandum, as well as the FRPCC 

technical information paper, is available 

on the OSTP Web site at http:// 

www.ostp.gov/KI. 

The OSTP Director’s determination 

waived Section 127(f) because a more 

effective preventive measure does exist 

for the extended zone covered by the 

Act, namely avoidance of exposure 

altogether through evacuation of the 

potentially affected population and 

interdiction of contaminated food. 

Analysis of radiological release events 

that could lead to adverse thyroid 

conditions beyond the current 10 mile 

zone shows that limiting or avoiding 

exposure to radiation through these 

mechanisms is practical and much more 

effective than the administration of KI 

in the proposed extended zone. 

DATES: The Decision Memorandum was 

executed on January 22, 2008. 

Associated documents will be available 

on the OSTP Web site on January 31, 

2008. 

ADDRESSES: Questions concerning this 

Notice should be sent to OSTP by e-mail 

at comments@ostp.eop.gov or by Fax at 

202–456–6027. 

Background 

Section 127(a) of the Act directs the 

President to establish a KI distribution 

program as discussed above. Section 

127(b) of the Act calls for State and local 

authorities to submit their KI stockpile 

plans to the President. Section 127(c) 

requires the President to issue 

guidelines for the stockpiling of KI 

tablets. Section 127(d) requires the 

Federal government to undertake efforts 

to make states and localities aware of 

the availability of KI under 127(a). 

Section 127(e) requires the President to 


rwilkins on PROD1PC63 with NOTICES